Measles, Mumps and Rubella (MMR) Vaccines Market Estimated to Record Highest CAGR by 2026

Page 1

Measles, Mumps and Rubella (MMR) Vaccines Market To Register Unwavering Growth During in Global by 2026

Measles, Mumps and Rubella (MMR) Vaccines Market, by Product Type (Monovalent, and Combinational (Divalent, Trivalent, and Others)) and by End Users (Hospitals, Healthcare Centers, and Others) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018 – 2026

Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as combinational vaccines. Combinational MMR vaccines comprises mixture of two or more viral strains. Click to Read More On Measles, Mumps and Rubella (MMR) Vaccines Market. These measles, mumps, and rubella vaccines are administered by subcutaneous injection to children as well as adults. It is generally administered to children aged 1 year and second dosage can be administered as early as one month after the first dose. According to CDC, two doses of measles, mumps and rubella vaccine are 97% effective against measles and 88% effective against mumps. One


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.